Oxlumo Covered With Prior Authorization

Harvard Pilgrim now covers Oxlumo (HCPCS code J0224: Injection, lumasiran, 0.5 mg), with prior authorization, for members of our commercial plans.

Oxlumo is indicated for the treatment of primary hyperoxaluria type 1 to lower urinary oxalate levels in children and adults.

To request authorization, please contact CVS Health–NovoLogix via phone (844-387-1435) or fax (844-851-0882). For complete coverage criteria and other information, including FDA-approved maximum dosage and frequency limits, refer to Harvard Pilgrim’s commercial Oxlumo Medical Policy.


Publication Information

Helen Connaughton,
Director, Network Operations

Annmarie Dadoly,
Editor

Joseph O’Riordan,
Writer

Kristin Edmonston,
Production Coordinator